AAAAAA
Results: 1-25/30
Authors:
Bristow, MR
Shakar, SF
Linseman, JV
Lowes, BD
Citation: Mr. Bristow et al., Inotropes and beta-blockers: Is there a need for new guidelines?, J CARD FAIL, 7(2), 2001, pp. 8-12
Authors:
Schleman, KA
Lindenfeld, JA
Lowes, BD
Bristow, MR
Ferguson, D
Wolfel, EE
Abraham, WT
Zisman, LS
Citation: Ka. Schleman et al., Predicting response to carvedilol for the treatment of heart failure: A multivariate retrospective analysis, J CARD FAIL, 7(1), 2001, pp. 4-12
Authors:
Lindenfeld, J
Robertson, AD
Lowes, BD
Bristow, MR
Citation: J. Lindenfeld et al., Aspirin impairs reverse myocardial remodeling in patients with heart failure treated with beta-blockers, J AM COL C, 38(7), 2001, pp. 1950-1956
Authors:
Fowler, MB
Vera-Llonch, N
Oster, G
Bristow, MR
Cohn, JN
Colucci, WS
Gilbert, EM
Lukas, MA
Lacey, MJ
Richner, R
Young, ST
Packer, M
Citation: Mb. Fowler et al., Influence of carvedilol on hospitalizations in heart failure: Incidence, resource utilization and costs, J AM COL C, 37(6), 2001, pp. 1692-1699
Authors:
Asano, K
Zisman, LS
Yoshikawa, T
Headley, V
Bristow, MR
Port, JD
Citation: K. Asano et al., Bucindolol, a nonselective beta(1)- and beta(2)-adrenergic receptor antagonist, decreases beta-adrenergic receptor density in cultured embryonic chick cardiac myocyte membranes, J CARDIO PH, 37(6), 2001, pp. 678-691
Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.
Authors:
Yancy, CW
Fowler, MB
Colucci, WS
Gilbert, EM
Bristow, MR
Cohn, JN
Lukas, MA
Young, ST
Packer, M
Citation: Cw. Yancy et al., Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure., N ENG J MED, 344(18), 2001, pp. 1358-1365
Authors:
Port, JD
Bristow, MR
Citation: Jd. Port et Mr. Bristow, beta-adrenergic receptors, transgenic mice, and pharmacological model systems, MOLEC PHARM, 60(4), 2001, pp. 629-631
Authors:
Port, JD
Bristow, MR
Citation: Jd. Port et Mr. Bristow, Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure, J MOL CEL C, 33(5), 2001, pp. 887-905
Authors:
Freeman, K
Lerman, I
Kranias, EG
Bohlmeyer, T
Bristow, MR
Lefkowitz, RJ
Iaccarino, G
Koch, WJ
Leinwand, LA
Citation: K. Freeman et al., Alterations in cardiac adrenergic signaling and calcium cycling differentially affect the progression of cardiomyopathy, J CLIN INV, 107(8), 2001, pp. 967-974
Authors:
Kinugawa, K
Yonekura, K
Ribeiro, RCJ
Eto, Y
Aoyagi, T
Baxter, JD
Camacho, SA
Bristow, MR
Long, CS
Simpson, PC
Citation: K. Kinugawa et al., Regulation of thyroid hormone receptor isoforms in physiological and pathological cardiac hypertrophy, CIRCUL RES, 89(7), 2001, pp. 591-598
Authors:
Kinugawa, K
Minobe, WA
Wood, WM
Ridgway, EC
Baxter, JD
Ribeiro, RCJ
Tawadrous, MF
Lowes, BA
Long, CS
Bristow, MR
Citation: K. Kinugawa et al., Signaling pathways responsible for fetal gene induction in the failing human heart - Evidence for altered thyroid hormone receptor gene expression, CIRCULATION, 103(8), 2001, pp. 1089-1094
Authors:
Bristow, MR
Citation: Mr. Bristow, Of phospholamban, mice, and humans with heart failure, CIRCULATION, 103(6), 2001, pp. 787-788
Authors:
Bristow, MR
Feldman, AM
Saxon, LA
Citation: Mr. Bristow et al., Heart failure management using implantable devices for ventricular resynchronization: Comparison of medical therapy, pacing, and defibrillation in chronic heart failure (COMPANION) trial, J CARD FAIL, 6(3), 2000, pp. 276-285
Authors:
Bristow, MR
Citation: Mr. Bristow, Mechanistic and clinical rationales for using beta-blockers in heart failure, J CARD FAIL, 6(2), 2000, pp. 8-14
Authors:
Noori, A
Lindenfeld, J
Wolfel, E
Ferguson, D
Bristow, MR
Lowes, BD
Citation: A. Noori et al., beta-blockade in adriamycin-induced cardiomyopathy, J CARD FAIL, 6(2), 2000, pp. 115-119
Authors:
Lowes, BD
Higginbotham, M
Petrovich, L
DeWood, MA
Greenberg, MA
Rahko, PS
Dec, GW
LeJemtel, TH
Roden, RL
Schleman, MM
Robertson, AD
Gorczynski, RJ
Bristow, MR
Citation: Bd. Lowes et al., Low-dose enoximone improves exercise capacity in chronic heart failure, J AM COL C, 36(2), 2000, pp. 501-508
Authors:
Lowes, BD
Simon, MA
Tsvetkova, TO
Bristow, MR
Citation: Bd. Lowes et al., Inotropes in the beta-blocker era, CLIN CARD, 23(3), 2000, pp. 11-16
Authors:
Bristow, MR
Citation: Mr. Bristow, Best practices for optimal treatment of advanced heart failure, CLIN CARD, 23(3), 2000, pp. IV-IV
Authors:
Bisognano, JD
Weinberger, HD
Bohlmeyer, TJ
Pende, A
Raynolds, MV
Sastravaha, A
Roden, R
Asano, K
Blaxall, BC
Wu, SC
Communal, C
Singh, K
Colucci, W
Bristow, MR
Port, JD
Citation: Jd. Bisognano et al., Myocardial-directed overexpression of the human beta(1)-adrenergic receptor in transgenic mice, J MOL CEL C, 32(5), 2000, pp. 817-830
Authors:
Miyata, S
Minobe, W
Bristow, MR
Leinwand, LA
Citation: S. Miyata et al., Myosin heavy chain isoform expression in the failing and nonfailing human heart, CIRCUL RES, 86(4), 2000, pp. 386-390
Authors:
Bristow, MR
Citation: Mr. Bristow, What type of beta-blocker should be used to treat chronic heart failure?, CIRCULATION, 102(5), 2000, pp. 484-486
Authors:
Braunwald, E
Bristow, MR
Citation: E. Braunwald et Mr. Bristow, Congestive heart failure: Fifty years of progress, CIRCULATION, 102(20), 2000, pp. 14-23
Authors:
Bristow, MR
Citation: Mr. Bristow, beta-adrenergic receptor blockade in chronic heart failure, CIRCULATION, 101(5), 2000, pp. 558-569
Authors:
Quaife, RA
Lynch, D
Badesch, DB
Voelkel, NF
Lowes, BD
Robertson, AD
Bristow, MR
Citation: Ra. Quaife et al., Right ventricular phenotypic characteristics in subjects with primary pulmonary hypertension or idiopathic dilated cardiomyopathy, J CARD FAIL, 5(1), 1999, pp. 46-54
Authors:
Lindenfeld, J
Lowes, BD
Bristow, MR
Citation: J. Lindenfeld et al., Hypotension with dobutamine: beta-adrenergic antagonist selectivity at lowdoses of carvedilol, ANN PHARMAC, 33(12), 1999, pp. 1266-1269